Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06661252

Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders

Sponsor: Diag-Nose Medical Pty Ltd

View on ClinicalTrials.gov

Summary

This research study is an observational, single site study quantifying expression of biomarkers of respiratory disease in nasal fluid using the ABEL microsampler device. The primary objective of this study is to compare biomarker expression between healthy controls and participants with respiratory disorders such as chronic obstructive pulmonary disorder (COPD), hayfever, chronic sinusitis, asthma and rhinitis.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

250

Start Date

2025-01-08

Completion Date

2026-07

Last Updated

2025-06-06

Healthy Volunteers

Yes

Interventions

DEVICE

ABEL microsampler device

The ABEL microsampler device will be used to collect nasal fluid samples for biomarker analysis.

Locations (1)

Diag-Nose Medical

Notting Hill, Victoria, Australia